IRIS
VERDOIA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.100
EU - Europa 3.042
AS - Asia 1.955
SA - Sud America 334
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.023
RU - Federazione Russa 810
IE - Irlanda 650
SG - Singapore 556
CN - Cina 521
DE - Germania 481
SE - Svezia 336
HK - Hong Kong 300
VN - Vietnam 281
UA - Ucraina 260
BR - Brasile 249
FR - Francia 147
IN - India 132
IT - Italia 98
FI - Finlandia 84
GB - Regno Unito 74
CA - Canada 34
MX - Messico 34
AR - Argentina 33
IR - Iran 33
ID - Indonesia 27
PL - Polonia 27
BD - Bangladesh 18
ZA - Sudafrica 18
NL - Olanda 17
ES - Italia 15
JP - Giappone 15
EC - Ecuador 14
IQ - Iraq 14
PY - Paraguay 11
CO - Colombia 9
CZ - Repubblica Ceca 9
KR - Corea 9
AT - Austria 8
LT - Lituania 7
TR - Turchia 7
UZ - Uzbekistan 7
JM - Giamaica 6
VE - Venezuela 6
CL - Cile 5
MA - Marocco 5
PH - Filippine 5
UY - Uruguay 5
BE - Belgio 4
DZ - Algeria 4
EG - Egitto 4
PK - Pakistan 4
AU - Australia 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
NG - Nigeria 2
OM - Oman 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.482
Salva come PNG Salva come JPEG
Città #
Dublin 650
Jacksonville 504
San Jose 407
Hong Kong 300
Dearborn 248
Singapore 206
Ashburn 198
Wilmington 168
Beijing 160
Moscow 120
Chandler 97
Lawrence 86
Princeton 86
Los Angeles 81
Bremen 80
Lauterbourg 78
Ho Chi Minh City 72
Council Bluffs 60
Hanoi 56
Düsseldorf 41
New York 41
San Mateo 37
São Paulo 35
Buffalo 34
Orem 30
Redondo Beach 28
Santa Clara 27
Ann Arbor 23
Munich 23
Dong Ket 20
Frankfurt am Main 20
Denver 19
Mexico City 19
Warsaw 19
Woodbridge 19
Haiphong 18
Leawood 18
Andover 17
Monmouth Junction 17
Houston 16
Chennai 15
Hefei 15
Nanjing 15
Guangzhou 14
Johannesburg 14
Manchester 14
Poplar 14
Tokyo 14
Ardabil 13
Bexley 13
Dallas 13
Helsinki 13
Kunming 13
Norwalk 13
Piemonte 13
Torino 13
Brooklyn 11
Chicago 11
Seattle 11
Tianjin 11
Toronto 11
Biên Hòa 10
Columbus 10
Montreal 10
Phoenix 10
Augusta 9
Brno 9
Fairfield 9
Hangzhou 9
Seoul 9
Stockholm 9
Zanjan 9
Amsterdam 8
Da Nang 8
Jakarta 8
Jinan 8
New Delhi 8
Nuremberg 8
Atlanta 7
Novara 7
San Francisco 7
Shenyang 7
Tashkent 7
Belo Horizonte 6
Boston 6
London 6
Mumbai 6
Shenzhen 6
Turku 6
Ankara 5
Baghdad 5
Guayaquil 5
Hải Dương 5
Kingston 5
Montevideo 5
Ottawa 5
Sacramento 5
Thái Bình 5
Wenzhou 5
Brasília 4
Totale 4.728
Salva come PNG Salva come JPEG
Nome #
Modulation of 1,25(OH)2D levels in cardiovascular system. Genetic regulation, impact on coronary artery disease, inflammation, platelet function and periprocedural myocardial injury after percutaneous coronary interventions 173
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 137
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 136
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 130
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 130
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 128
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 126
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 125
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 124
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 124
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 119
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 118
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 118
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 118
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 117
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 117
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 116
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 116
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 115
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 115
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 114
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 114
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 114
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 113
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 113
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 112
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 111
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 111
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 110
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 110
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 110
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 110
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 109
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 108
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 108
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 107
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 105
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 105
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 104
Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization. 103
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 103
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 103
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 102
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 101
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 99
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 99
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 98
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 98
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 97
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 97
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 95
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 95
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 94
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 94
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 94
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 93
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 92
Immature platelet fraction and the extent of coronary artery disease: A single centre study 91
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 88
Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease 87
Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy 87
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 86
Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study 86
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 83
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 82
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies. 81
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. 80
Statins and elderly: From clinical trials to daily practice 80
Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study. 79
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy 79
Two catheters for one perforation 78
Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment 78
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 77
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis 75
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 75
Impact of aging on immature platelet count and its relationship with coronary artery disease 72
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study. 69
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 68
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve 67
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents 67
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy 66
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention 66
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease 64
Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation 62
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI 62
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention 61
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort study 58
Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials 51
Targeted therapies in non–small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management 21
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management 18
Totale 8.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022502 23 40 38 34 47 7 15 13 32 29 105 119
2022/20231.278 92 52 85 6 108 107 25 85 645 3 45 25
2023/2024448 30 40 35 6 69 0 48 7 1 4 142 66
2024/2025739 23 15 23 2 41 5 81 128 189 73 10 149
2025/20263.591 168 120 273 603 302 258 629 612 188 224 156 58
Totale 8.691